IRCCS Azienda Ospedaliero-Universitaria di Bologna – Policlinico Sant'Orsola
Bologna's university hospital, home of the Seràgnoli haematology institute and a leading Italian centre for myeloma, lymphoma and CAR-T.
The Policlinico Sant'Orsola is the university hospital of the world's oldest university and an IRCCS for transplant and oncology. Its Seràgnoli Institute of Haematology, associated with Michele Cavo (myeloma), Pier Luigi Zinzani (lymphoma) and the GIMEMA cooperative group, has run pivotal Italian trials in myeloma transplantation and lymphoma and is one of Italy's principal CAR-T and allogeneic transplant centres. Medical oncology under Andrea Ardizzoni is active in thoracic and gastrointestinal trials, and the hospital has large paediatric oncology, surgical oncology and nuclear medicine departments. The Emilia-Romagna regional network links it with IRST Meldola.
- Seràgnoli haematology institute
- Myeloma and lymphoma trials (GIMEMA)
- CAR-T and transplantation
- Thoracic oncology
- Paediatric oncology
Pages like this
not linked directly; found by shared links- InstitutionComprehensive Cancer Center Mainfranken, University Hospital Würzburg
Shares Teclistamab, BCMA, Bispecific antibodies, Multiple myeloma.
- IdeaPlan the second CAR-T target before the first one is lost
Shares CD20, BCMA, Allogeneic (off-the-shelf) cell therapy, Multiple myeloma.
- InstitutionSeoul St. Mary's Hospital
Shares Allogeneic (off-the-shelf) cell therapy, Multiple myeloma, Acute myeloid leukaemia, Diffuse large B-cell lymphoma.
- InstitutionUnion Hospital, Tongji Medical College
Shares BCMA, Multiple myeloma, Diffuse large B-cell lymphoma, CAR-T cell therapy.
- PersonStephen J. Forman
Shares Allogeneic (off-the-shelf) cell therapy, Acute myeloid leukaemia, Diffuse large B-cell lymphoma, CAR-T cell therapy.
- InstitutionChristian Medical College, Vellore
Shares Allogeneic (off-the-shelf) cell therapy, Multiple myeloma, Acute myeloid leukaemia, CAR-T cell therapy.
- InstitutionIUCT Oncopole – Institut Universitaire du Cancer de Toulouse
Shares Teclistamab, Bispecific antibodies, Multiple myeloma, CAR-T cell therapy.
- InstitutionEuropean Hematology Association
Shares Bispecific antibodies, Hodgkin lymphoma, Multiple myeloma, Acute myeloid leukaemia.